Antigen, Invasive Fungal Pathogens
Microbiology · 21 CFR 866.3050
Invasive fungal pathogen assays are devices that consist of antigens, antisera, or proteases used in serological assays for the presumptive diagnosis of fungal infection in serum or plasma. The assay is indicated for use in patients with symptoms of, or medical conditions predisposing the patient to invasive fungal infection. The device can be used as an aid in the diagnosis of deep seated mycoses and fungemias. A positive result does not indicate which class of fungi may be causing infection. The assays should be used in conjunction with other diagnostic procedures, such as microbiological culture, histological examination of biopsy samples and radiological examination.
Recent MDR events
0 adverse event reports on file
No MDR events on file for this product code.
Event type breakdown
No data available.
Most-reported manufacturers
No data available.
Recalls
2 recall events for this product code
- Associates of Cape Cod, Inc.TerminatedUnknown
Fungitell Kit, Catalog FT001 - Product Usage: The Fungitell assay is a potease zymogen-based colorimetric assay for the qualitative detection of (1-3)Beta-D Glu
The kits may contain the incorrect number of components or the kits may be missing components.
Z-1329-2019 · View FDA record ↗ - Associates of Cape Cod, Inc.TerminatedUnknown
Fungitell STAT- IVD Assay for (1 3)-~-D-Glucan in Serum
Incorrect information on the Fungitell STAT clamshells containing the Fungitell STAT Standard, relates to printed information for reconstitution and pretreatment volumes
Z-1774-2022 · View FDA record ↗
Registered firms
2 firms currently registered for this product code
510(k) clearances
2 clearances for this product code